This site is intended for healthcare professionals only
LoginRegister
Pharmacy Trader Loses Rs 6.7 Crore to Fake Investment App FraudPharmacy Trader Loses Rs 6.7 Crore to Fake Investment App Fraud
Lupin Gets Zero USFDA Observations for Nagpur PlantLupin Gets Zero USFDA Observations for Nagpur Plant
plant explosionPharma Plant Destroyed in Massive Choutuppal Explosion
Natco gets nod for SemaglutideNatco Pharma's Generic Semaglutide to Hit Indian Market in March
Lupin Appoints FMCG Veteran Anand Kripalu as Independent DirectorLupin Appoints FMCG Veteran Anand Kripalu as Independent Director
WHO Grants Phase II PQ to Biological Es Novel Oral Polio Vaccine Type 2WHO Grants Phase II PQ to Biological E's Novel Oral Polio Vaccine Type 2
AbbVie Challenges CMS Decision to Impose Price Caps on BotoxAbbVie Challenges CMS Decision to Impose Price Caps on Botox
Pharma Companies Told to Cut Prices of 17 Duty Exempt Cancer DrugsPharma Companies Told to Cut Prices of 17 Duty Exempt Cancer Drugs
Zydus Settles Mirabegron Patent Dispute With Astellas for USD 120 MillionZydus Settles Mirabegron Patent Dispute With Astellas for USD 120 Million
Sanofi Replaces CEO Paul Hudson Amid Vaccine Headwinds, Names Belen Garijo SuccessorSanofi Replaces CEO Paul Hudson Amid Vaccine Headwinds, Names Belen Garijo Successor
Lupin Appoints Dr Kushkumar Thakare as Manager, Medical Affairs for India RegionLupin Appoints Dr Kushkumar Thakare as Manager, Medical Affairs for India Region
USFDA Concludes PAI at Cipla Subsidiary InvaGen With 2 ObservationsUSFDA Concludes PAI at Cipla Subsidiary InvaGen With 2 Observations
X